Back to News
Market Impact: 0.3
IDEXX Buys CoVetAI To Expand Veterinary Workflow Intelligence
Source: Nasdaq
M&A & RestructuringArtificial IntelligenceTechnology & InnovationHealthcare & Biotech
IDEXX Laboratories acquired CoVetAI, a provider of AI-native ambient listening and clinical workflow software for veterinary practices. Financial terms were not disclosed. The deal expands IDEXX's veterinary-practice technology capabilities and AI exposure, though the immediate financial impact cannot be assessed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
IDXX0.45
More News
- Why Wendy’s is losing the burger wars—and is now a takeover target for Nelson Peltz
- Companies promised AI gains— here's how the payoff showed up in earnings
- AWS grows 39% and Amazon will spend even more on AI in 2027
- Stocks started the week with promise but ended in despair. Our take on the big reversal
- Fears over $828 billion AI capex spending spree help erase $1 trillion in market value
- Intel stock plunges 29%. Analysts urge caution on buying the dip